Commented Articles

PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.

NAFLD burden in Saudi Arabia and United Arab Emirates

Morbidity related to NAFLD and resulting NASH is likely to increase dramatically in the coming decades, especially in the Gulf countries, where there is already an epidemic of obesity and diabetes melittus. In their article, K. Alswat et al. (Liver Disease Research Center, College of Medicine, King Saud University, Riyad) estimated...
Read MoreNAFLD burden in Saudi Arabia and United Arab Emirates

Machine learning-based approach to liver histology assessment

Manual histologic assessment is currently the accepted standard for diagnosing and monitoring disease progression in nonalcoholic steatohepatitis (NASH), but is limited by variability in interpretation and insensitivity to change. A. Taylor-Weiner et al. (PathAI, Boston, Massachusetts, USA) describe here a machine learning-based approach to liver...
Read MoreMachine learning-based approach to liver histology assessment

Mechanisms, screening, prevention, and management of CVD in patients with NAFLD

Cardiovascular disease, rather than liver decompensation, remains the leading cause of morbidity and mortality in patients with NAFLD and NASH. A significant proportion of the cardiovascular risk in NASH is likely attributable to shared metabolic risk factors. Nevertheless, there is much interest in understanding the independent contribution...
Read MoreMechanisms, screening, prevention, and management of CVD in patients with NAFLD

Significant fatigue and pruritus are common in patients with advanced NASH

Although early stages of NASH may not be associated with severe symptoms, it is increasingly appreciated that NASH is not an asymptomatic disease. In fact, systematic assessments of patients with NASH using validated health-related quality- of-life instruments suggest significant impairment of patient-reported outcomes...
Read MoreSignificant fatigue and pruritus are common in patients with advanced NASH

Impact of Ramadan fasting on NASH severity

The aim of the current study by A. Mari et al. (Nazareth Hospital EMMS, Nazareth, and Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) was to assess the impact of caloric restrictions during Ramadan fasting on severity index of NASH severity scores. The authors conducted a retrospective, case control study in Nazareth Hospital...
Read MoreImpact of Ramadan fasting on NASH severity

Review: Non-invasive tests of hepatic steatosis and fibrosis: confounding factors

Non-invasive tests of NAFLD can be classified by the target disease state or the type of test. Disease states of interest include the detection of hepatic steatosis (for the diagnosis of NAFLD or using steatosis improvement as treatment outcomes in early phase studies)...
Read MoreReview: Non-invasive tests of hepatic steatosis and fibrosis: confounding factors

Review: Tumour incidence in patients with NAFLD

The spectrum that ranges from non-alcoholic fatty liver disease (NAFLD) to the more aggressive form of non-alcoholic steatohepatitis (NASH) all the way to liver cirrhosis is associated with complications and hepatocellular carcinoma. Extrahepatic malignancies are among the leading causes of death in patients with NAFLD, but little is known about...
Read MoreReview: Tumour incidence in patients with NAFLD

NAFLD and heart failure with preserved LV ejection fraction

The prevalence of NAFLD in heart failure preserved left ventricular ejection fraction (HFpEF) patients could reach 50%. Therefore, NAFLD is considered an emerging risk factor. The purpose of this review by R. Itier et al. (Department of Cardiology, CHU, Toulouse, France) is to provide an overview of the relationships between NAFLD...
Read MoreNAFLD and heart failure with preserved LV ejection fraction